Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Drug repurposing

Existing drugs are effective against human parainfluenza virus

Study shows that suramin combined with zanamivir acts synergistically to inhibit human parainfluenza type-3 virus infection.

Micrograph of the human parainfluenza virus

Source: CDC

Human parainfluenza viruses (pictured) commonly cause respiratory illnesses in infants and young children

Human parainfluenza type-3 virus (hPIV-3) is the second most common cause of acute respiratory tract infection in infants, but there are currently no drugs or vaccines available against it.

Researchers from Griffith University in Queensland, Australia, explored whether existing drugs are able to target a particular receptor on the envelope surface of hPIV-3.

Through a screening process, they found that suramin, a drug commonly used for sleeping sickness in Africa, can inhibit hPIV-3 enzyme activity via this receptor. And when the researchers combined suramin with the anti-influenza drug zanamivir, they discovered the drugs act synergistically to inhibit hPIV-3 infection in vitro.

Writing in Scientific Reports[1] (online, 7 April 2016), the team say the findings show the potential of drug repurposing for treating parainfluenza and suggest that treating patients with both drugs together could allow lower doses to be used.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2016.20201000

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Micrograph of the human parainfluenza virus

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.